Keywords: GlaxoSmithKlline, Futura, Pain drug TPR100, Medivir, Xerclear, Biospherics, Dtagatose

GlaxoSmithKline bags rights to Futura’s pain drug TPR100; Biospherics gets patent to develop Dtagatose from Kentucky University

Article | 01 July 2010

Print This

Futura Medical, a UK developer of innovative products for consumer health care, has signed a development agreement with UK drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in